Phase II study of DFP-10917, a deoxycytidine analog, given by 14-day continuous intravenous infusion for chemotherapy-refractory advanced colorectal cancer

Por Sarshekeh, Amir Mehrvarz, Xiong, Henry Q., Iizuka, Kenzo, Hochster, Howard S., Kopetz, Scott
Publicado no Invest New Drugs (2018)

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial

Por Brümmendorf, Tim H, Cortes, Jorge E, de Souza, Cármino Antonio, Guilhot, Francois, Duvillié, Ladan, Pavlov, Dmitri, Gogat, Karïn, Countouriotis, Athena M, Gambacorti-Passerini, Carlo
Publicado no Br J Haematol (2015)

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

Por Hochhaus, A, Saglio, G, Hughes, T P, Larson, R A, Kim, D-W, Issaragrisil, S, le Coutre, P D, Etienne, G, Dorlhiac-Llacer, P E, Clark, R E, Flinn, I W, Nakamae, H, Donohue, B, Deng, W, Dalal, D, Menssen, H D, Kantarjian, H M
Publicado no Leukemia (2016)

RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial

Por Lim, Sean H., Linton, Kim M., Collins, Graham P., Dhondt, Joke, Caddy, Joshua, Rossiter, Liz, Vadher, Karan, Fines, Keira, Rogers, Laura E., Fernando, Diana, Stanton, Louise, Davies, Andrew J., Johnson, Peter W. M., Griffiths, Gareth
Publicado no Trials (2018)

A Phase 2 Study of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer Who Had Received Docetaxel-based Chemotherapy

Por Satoh, Takefumi, Uemura, Hiroji, Tanabe, Kazunari, Nishiyama, Tsutomu, Terai, Akito, Yokomizo, Akira, Nakatani, Tatsuya, Imanaka, Keiichiro, Ozono, Seiichiro, Akaza, Hideyuki
Publicado no Jpn J Clin Oncol (2014)

Treatment rationale and design of the RAMNITA study: A phase II study of the efficacy of docetaxel...

Por Tanimura, Keiko, Uchino, Junji, Tamiya, Nobuyo, Kaneko, Yoshiko, Yamada, Tadaaki, Yoshimura, Kenichi, Takayama, Koichi
Publicado no Medicine (Baltimore) (2018)

A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for T2N0 Rectal Cancer: Preliminary Results of the ACOSOG Z6041 Trial

Por Garcia-Aguilar, Julio, Shi, Qian, Thomas, Charles R., Chan, Emily, Cataldo, Peter, Marcet, Jorge, Medich, David, Pigazzi, Alessio, Oommen, Samuel, Posner, Mitchell C.
Publicado no Ann Surg Oncol (2011)

Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European...

Por Raymond, Eric, Brandes, Alba A., Dittrich, Christian, Fumoleau, Pierre, Coudert, Bruno, Clement, Paul M.J., Frenay, Marc, Rampling, Roy, Stupp, Roger, Kros, Johan M., Heinrich, Michael C., Gorlia, Thierry, Lacombe, Denis, van den Bent, Martin J.
Publicado em 2008

Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study

Por Long, G. V., Atkinson, V., Ascierto, P. A., Robert, C., Hassel, J. C., Rutkowski, P., Savage, K. J., Taylor, F., Coon, C., Gilloteau, I., Dastani, H. B., Waxman, I. M., Abernethy, A. P.
Publicado no Ann Oncol (2016)

A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab...

Por Dotan, Efrat, Meropol, Neal J., Burtness, Barbara, Denlinger, Crystal S., Lee, James, Mintzer, David, Zhu, Fang, Ruth, Karen, Tuttle, Holly, Sylvester, Judi, Cohen, Steven J.
Publicado em 2012

Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)

Por Hurt, CN, Jones, SEF, Madden, T‐A, Fiander, A, Nordin, AJ, Naik, R, Powell, N, Carucci, M, Tristram, A
Publicado no BJOG (2018)

Nimotuzumab plus paclitaxel and cisplatin as the first line treatment for advanced esophageal squamous cell cancer: A single centre prospective phase II trial

Por Lu, Ming, Wang, Xicheng, Shen, Lin, Jia, Jun, Gong, Jifang, Li, Jie, Li, Jian, Li, Yan, Zhang, Xiaotian, Lu, Zhihao, Zhou, Jun, Zhang, Xiaodong
Publicado no Cancer Sci (2016)

Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients...

Por Goss, Glenwood, Ferry, David, Wierzbicki, Rafal, Laurie, Scott A., Thompson, Joyce, Biesma, Bonne, Hirsch, Fred R., Varella-Garcia, Marileila, Duffield, Emma, Ataman, Ozlem U., Zarenda, Marc, Armour, Alison A.
Publicado no J Clin Oncol (2009)

A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced...

Por Zheng, Yi, Tu, Xiaoxuan, Zhao, Peng, Jiang, Weiqin, Liu, Lulu, Tong, Zhou, Zhang, Hangyu, Yan, Cong, Fang, Weijia, Wang, Weilin
Publicado no Br J Cancer (2018)

P01.060 PriCoTTF: a phase I/II trial of Tumor Treating Fields prior and concomitant to radiotherapy in newly diagnosed glioblastoma

Por Glas, M, Scheffler, B, Lazaridis, L, Herrlinger, U, Pierscianek, D, Sure, U, Pröscholdt, M, Hau, P, Hense, J, Kleinschnitz, C, Grosu, A, Stuschke, M, Kebir, S
Publicado no Neuro Oncol (2018)

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Por Aparicio, T, Bouché, O, Taieb, J, Maillard, E, Kirscher, S, Etienne, P -L, Faroux, R, Khemissa Akouz, F, El Hajbi, F, Locher, C, Rinaldi, Y, Lecomte, T, Lavau-Denes, S, Baconnier, M, Oden-Gangloff, A, Genet, D, Paillaud, E, Retornaz, F, François, E, Bedenne, L
Publicado no Ann Oncol (2018)

A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination...

Por Engel-Riedel, Walburga, Lowe, Jamie, Mattson, Paulette, Richard Trout, J., Huhn, Richard D., Gargano, Michele, Patchen, Myra L., Walsh, Richard, Trinh, My My, Dupuis, Mariève, Schneller, Folker
Publicado no J Immunother Cancer (2018)

Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial

Por Yu, Jeong Il, Park, Hee Chul, Jung, Sang Hoon, Choi, Changhoon, Shin, Sung Wook, Cho, Sung Ki, Sinn, Dong Hyun, Paik, Yong-Han, Gwak, Geum-Youn, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Yoo, Byung Chul, Sahinbas, Hüseyin, Paik, Seung Woon
Publicado no Oncotarget (2017)

Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study

Por Struller, Florian, Horvath, Philipp, Solass, Wiebke, Weinreich, Frank-Jürgen, Strumberg, Dirk, Kokkalis, Marios K., Fischer, Imma, Meisner, Christoph, Königsrainer, Alfred, Reymond, Marc A.
Publicado no Ther Adv Med Oncol (2019)

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic...

Por Lee, Choong-kun, Jung, Minkyu, Choi, Hye Jin, Kim, Hye Ryun, Kim, Hyo Song, Roh, Mi Ryung, Ahn, Joong Bae, Chung, Hyun Cheol, Heo, Su Jin, Rha, Sun Young, Shin, Sang Joon
Publicado no Cancer Res Treat (2015)